The situation is exacerbated across Africa and other LMICs by concerns with access and availability of insulins including NPH and short-acting insulins in the first place as well as limited facilities and equipment to diagnose diabetes and enable patients to regularly monitor their insulin levels to reduce hypoglycaemia (18, 36, 38–41). Here, INS is linked to diabetes mellitus.